Financial Support

Martin Miralda was fresh out of college when a short visit to the United States helped to save his life after he was diagnosed with leukemia. Despite his lacking health insurance as a non-resident, he received superior medical care through “Charity Care,” a service that covers necessary hospitalization for uninsured people in the country and is available in several states.

A new legislation proposed by the Trump administration aims at lowering the price of prescription drugs, especially the high cost of cancer drugs, for patients.

Clara Lambert explains the areas addressed by the financial navigator and walks through the role of the financial navigator in addressing the patient's financial burden relative to their care.

After facing the potential financial burden of his own medical bills, cancer survivor David Mitchell founded Patients for Affordable Drugs, a nonprofit organization aimed to control the cost of drugs and make them affordable for patients with cancer.

Fly through barriers to cancer care with the Air Charity Network. This nationwide network has volunteer pilots who fly patients with cancer to their treatment around the country, entirely free.

The following financial support services are available for patients with multiple myeloma. For more information, see the full 2018 Patient Guide to Cancer Support Services.

Lillie Shockney addresses the prevalent issue of financial toxicity and identifies a number of resources and services that can help patients and families manage the cost of cancer care.

A look at valuable resources that can help patients and their loved ones alleviate the financial burden of paying for lodging while undergoing treatment.

The Emilio Nares Foundation, located in San Diego, CA, helps children and their families navigate through a cancer diagnosis with valuable services, from a cost-saving transportation program to modified shirts with easy access to chemotherapy ports.

Drug development is an expensive and laborious process for drug companies, and involves conducting years of research in the lab, followed by years of clinical trials with patients, before a drug gets through the FDA review and approval (or rejection), and then onto the market.

Many patients with cancer face a serious financial burden, and some are missing treatment or skipping treatment altogether because of the cost.